IMLYGIC® (talimogene laherparepvec; T-VEC) ACTION PLAN
The content in this action plan is intended to aid you in educating your patient with melanoma about how to take Imlygic. In addition, the customizable content provides key written information on safety aspects and adverse-event management. Below is a brief description of the different pages available to you and how to use them. Whether you print this whole action plan or just certain pages, we trust that you will find this resource from the MNI a helpful companion to our healthcare provider materials.
You can choose to print whichever pages/sections you would like. You also have the option of reading the annotations for each page before printing or just selecting the specific pages by title below, and downloading.